Division of Vascular Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Asanbyeongwon-gil 86, Songpa-gu, Seoul, 05505, Republic of Korea.
Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Eur Radiol. 2019 Dec;29(12):6591-6599. doi: 10.1007/s00330-019-06306-5. Epub 2019 Jun 27.
This study aimed to identify new predictors of sac behavior after endovascular aortic aneurysm repair (EVAR) and to investigate whether sac behavior is associated with long-term clinical outcomes.
A total of 168 patients undergoing successful EVAR for abdominal aortic aneurysms with CTA follow-up of at least 1 year were included. Predictors of aneurysm sac behavior and its impact on long-term clinical outcomes were retrospectively analyzed.
According to sac behavior, eligible patients were stratified into the sac regression group (n = 79, 47.0%) and the sac non-regression group (n = 89, 53.0%). Patients in the regression group were younger (p = 0.036) and more likely to take sarpogrelate hydrochloride postoperatively (p = 0.011) than those in the non-regression group. The incidence of postimplantation syndrome (PIS) was significantly higher in the regression group (p = 0.005). On multivariate analysis, sac regression was more likely to occur in those with PIS (hazard ratio [HR], 1.68; 95% confidence interval [CI], 1.07-2.64; p = 0.023) and less likely to occur in those with transient type II endoleaks (HR, 0.43; 95% CI, 0.20-0.95; p = 0.037) and higher thrombus density within the sac on follow-up CTA (HR, 0.97; 95% CI, 0.95-0.99; p = 0.013). Non-regression of the sac was associated with significantly higher rates of re-intervention during the follow-up period (p = 0.001).
In addition to type II endoleaks, PIS and thrombus density are new predictors of aneurysm sac behavior, and sac regression is significantly associated with lower rates of re-intervention.
• After endovascular aortic aneurysm repair (EVAR), patients with sac regression were younger and more likely to take sarpogrelate hydrochloride postoperatively than those with sac non-regression. • The incidence of postimplantation syndrome (PIS) was significantly higher in patients with sac regression. • In our analysis, PIS and thrombus density within the sac were newly identified predictors of aneurysm sac behavior after EVAR.
本研究旨在确定血管内主动脉瘤修复(EVAR)后瘤囊行为的新预测因素,并探讨瘤囊行为是否与长期临床结局相关。
共纳入 168 例接受成功 EVAR 治疗的腹主动脉瘤患者,CTA 随访时间至少 1 年。回顾性分析了预测瘤囊行为的因素及其对长期临床结局的影响。
根据瘤囊行为,将符合条件的患者分为瘤囊回缩组(n=79,47.0%)和瘤囊无回缩组(n=89,53.0%)。与无回缩组相比,回缩组患者更年轻(p=0.036)且术后更可能服用沙格雷酯(p=0.011)。在回缩组中,植入后综合征(PIS)的发生率显著更高(p=0.005)。多因素分析显示,PIS 患者更有可能发生瘤囊回缩(风险比[HR],1.68;95%置信区间[CI],1.07-2.64;p=0.023),而发生一过性 II 型内漏(HR,0.43;95%CI,0.20-0.95;p=0.037)和瘤囊内血栓密度升高(HR,0.97;95%CI,0.95-0.99;p=0.013)的可能性较低。瘤囊无回缩与随访期间再干预率显著升高相关(p=0.001)。
除了 II 型内漏外,PIS 和瘤囊内血栓密度也是瘤囊行为的新预测因素,瘤囊回缩与再干预率降低显著相关。
• 在 EVAR 后,瘤囊回缩患者比瘤囊无回缩患者更年轻且更可能术后服用沙格雷酯。• 瘤囊回缩患者的植入后综合征(PIS)发生率显著更高。• 在我们的分析中,PIS 和瘤囊内血栓密度是 EVAR 后瘤囊行为的新确定预测因素。